The companies said their vaccine helped prevent the return and spread of melanoma in a trial that involved more than 1,000 patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results